COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study

[Image: see text] Background Comorbid conditions, including solid and hematologic malignancies, may impact risk of contracting SARS CoV-2 or having severe COVID-19. Data specific to individual cancer types is essential to differentiate impact of patient, disease, and therapy specific factors on risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Rea, Delphine, Mauro, Michael J., Cortes, Jorge E., Jiang, Qian, Pagnano, Katia B, Ongondi, Matilda, Kok, Chung Hoow, Evans, Nicola, Hughes, Timothy P., Foundation, International CML
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
632.Chronic Myeloid Leukemia: Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330226/
http://dx.doi.org/10.1182/blood-2020-140161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330226/
http://dx.doi.org/10.1182/blood-2020-140161

Ejemplares similares